Bioactivity:

ML-193 is a potent and selective GPR55 antagonist( IC50 : 221 nM). It shows more than 27-fold selectivity for GPR55 over GPR35, CB1 and CB2, and can improve the motor and the sensorimotor deficits of Parkinson�s disease (PD) rats.

CAS nr:

713121-80-3

Purity:

98%

Molecular Weight:

527,59

SMILES:

Cc1c(NS(c(cc2)ccc2NC(c2cc(-c3ncccc3)nc3c(C)cc(C)cc23)=O)(=O)=O)onc1C

Formula:

C28H25N5O4S

Pathway:

GPCR/G Protein

Target:

Cannabinoid Receptor